Cutter & Co Brokerage’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-36,279
| Closed | -$480K | – | 236 |
|
|
2024
Q4 | $480K | Sell |
36,279
-4,906
| -12% | -$65K | 0.12% | 101 |
|
|
2024
Q3 | $586K | Sell |
41,185
-789
| -2% | -$11.2K | 0.13% | 91 |
|
|
2024
Q2 | $543K | Buy |
41,974
+1,347
| +3% | +$17.4K | 0.13% | 93 |
|
|
2024
Q1 | $564K | Buy |
40,627
+2,813
| +7% | +$39.1K | 0.14% | 89 |
|
|
2023
Q4 | $540K | Buy |
37,814
+638
| +2% | +$9.1K | 0.15% | 89 |
|
|
2023
Q3 | $575K | Buy |
37,176
+1,535
| +4% | +$23.7K | 0.17% | 83 |
|
|
2023
Q2 | $560K | Buy |
35,641
+1,004
| +3% | +$15.8K | 0.17% | 88 |
|
|
2023
Q1 | $571K | Buy |
34,637
+282
| +0.8% | +$4.65K | 0.18% | 89 |
|
|
2022
Q4 | $536K | Sell |
34,355
-2,920
| -8% | -$45.6K | 0.18% | 90 |
|
|
2022
Q3 | $483K | Sell |
37,275
-4,581
| -11% | -$59.4K | 0.18% | 102 |
|
|
2022
Q2 | $588K | Buy |
41,856
+4,890
| +13% | +$68.7K | 0.2% | 97 |
|
|
2022
Q1 | $529K | Buy |
36,966
+3,115
| +9% | +$44.6K | 0.16% | 111 |
|
|
2021
Q4 | $461K | Buy |
33,851
+5,551
| +20% | +$75.6K | 0.13% | 135 |
|
|
2021
Q3 | $464K | Buy |
+28,300
| New | +$464K | 0.11% | 167 |
|